The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus.

Source:http://linkedlifedata.com/resource/pubmed/id/12388590

J. Neurosci. 2002 Oct 15 22 20 8838-49

Download in:

View as

General Info

PMID
12388590